Literature DB >> 10822235

Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly.

M Giusti, P Sessarego, G Timossi, L Bocca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10822235     DOI： 10.1530/eje.0.1420697

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN： 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  1 in total

1.  Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: a retrospective, comparative, head-to-head study.

Authors:  R S Auriemma; R Pivonello; M Galdiero; M C De Martino; M De Leo; G Vitale; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.